EGFR new study: Grb2 phosphorylation and Ras
A 2026 PLoS ONE paper on Grb2 phosphorylation and EGFR condensates, placed in context with DepMap, ChEMBL, Open Targets and CIViC data as of 2026-11-06.
BioQ Blog
Every BioQ post about EGFR: real search results, sources and the query to repeat it.
A 2026 PLoS ONE paper on Grb2 phosphorylation and EGFR condensates, placed in context with DepMap, ChEMBL, Open Targets and CIViC data as of 2026-11-06.
One query, osimertinib, returns phase counts for 188 registered ClinicalTrials.gov studies and a status table, with EGFR drug context, as of 2026-11-06.
EGFR vs ERBB2 in DepMap Chronos data and drug annotations: 224 of 1178 EGFR-dependent lines versus 177 for ERBB2, and 118 versus 59 known drugs.
One query, EGFR gefitinib, returns IC50 binding measurements, trial counts and CIViC evidence for the pair from three resources, as of 2026-11-06.